The OAFI Foundation and the University of Barcelona collaborate in the training of health professionals in the field of osteoarthritis

The OAFI Foundation and the University of Barcelona collaborate in the training of health professionals in the field of osteoarthritis

Dr. Josep Vergés (OAFI) and Dr. Amàlia Lafuente (UB) at OAFI’s headquarters

 

The Osteoarthritis Foundation International (OAFI) and the Pharmacology Unit of the Faculty of Medicine and Health Sciences (Campus Clinic) of the University of Barcelona have signed an agreement whereby both entities will collaborate in the training of health professionals, psychologists, nurses and physiotherapists, in the prevention and treatment of osteoarthritis patients (elderly, athletes, postmenopausal women and children), so that they provide their patients with the necessary tools to self-manage her illness.

Dr. Josep Vergés, President of OAFI has commented: “Osteoarthritis is a serious disease that is increasingly present in our society. Currently in Spain more than 7 million people suffer OA and the tendency is that its incidence continues to increase. It is necessary to have trained health professionals, nurses, physiotherapists and psychologists capable of responding to the health demands of patients with osteoarthritis and who can offer safe and effective diagnoses and treatments to improve their quality of life. ”

On the other hand, Dr. Amalia Lafuente, professor of Pharmacology at the Faculty of Medicine and Health Sciences at the University of Barcelona, ​​said: “From our Unit we will collaborate with the Foundation by providing our training capacity in different pharmacological fields as well as in lifestyle, so that the osteoarthritis patient can correctly manage his illness. ”

With the signing of this collaboration agreement, the University of Barcelona is part of the World Association of Osteoarthritis, a network led by OAFI which is formed by associations of patients, medical societies, research centers and public administrations, among other agents involved in the investigation and awareness of this pathology and in the improvement of the joint health of society. The agreement will help the development of professionals, knowledge, research and training in osteoarthritis.

Osteoarthritis. Description of the disease and epidemiological data

Osteoarthritis is a severe degenerative joint disease that affects both cartilage and bone and soft tissue of the joint. It produces pain and limits us when it comes to doing our usual tasks. Globally, it is estimated that 242 million people suffer from it and in Spain the figure stands at 7 million patients. In addition, it is one of the main causes of permanent and temporary disability.

Osteoarthritis currently accounts for an average annual cost of 4,738 million euros for the Spanish Health System (focusing solely on osteoarthritis of the knee and hip) and, despite its social impact, remains an unknown and distant disease for the most part the population. However, it affects However, it affects a very fragmented patient population with very different needs: elderly, athletes, postmenopausal women and young people.